RegeneRx Biopharmaceuticals, Inc./ US75886X3061 /
13/06/2024 21:08:44 | Chg. -0.0508 | Volume | Bid- | Demandez à- | Haut | Bas |
---|---|---|---|---|---|---|
0.0014USD | -97.32% | 474 Chiffrre d'affaires: .6608 |
-Bid taille: - | -Ask la taille: - | 0.0014 | 0.0014 |
GlobeNewswire
00:45
Equinix (EQIX) Financials Under Scrutiny as Short Seller Dispute Intensifies - Hagens Berman June 1...
GlobeNewswire
00:43
Autodesk (ADSK) Accounting Probe Finds Manipulation of Financial Metrics– Hagens Berman
GlobeNewswire
00:22
Reno and TMWA Awarded $30 Million Federal “WaterSMART” Grant for Advanced Purified Water Facility
GlobeNewswire
00:22
AKRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Invest...
GlobeNewswire
13/06
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before I...
Newsfile Corp
13/06
GDRX DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secur...
GlobeNewswire
13/06
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sprout Social, Inc. Investors to Secure Counsel Befor...
GlobeNewswire
13/06
Kirby McInerney LLP Reminds Biogen, Inc. (BIIB) Investors of Class Action Filing and Encourages Inve...
GlobeNewswire
13/06
Enservco Corporation Provides Further Update on Plan to Regain Compliance with NYSE American Listing...
GlobeNewswire
13/06
SAVE THE DATE: NOVAGOLD 2024 Second Quarter Financial Results Release, Conference Call and Video Web...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page